These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 8964231)

  • 1. [Causal therapy of multiple sclerosis].
    Pöhlau D; Rieks M; Postert T; Hoffmann V; Przuntek H
    Dtsch Med Wochenschr; 1996 Nov; 121(45):1407-14. PubMed ID: 8964231
    [No Abstract]   [Full Text] [Related]  

  • 2. [Multiple sclerosis--recent advances in pathogenesis and treatment].
    Itoyama Y; Fujihara K; Nakashima I; Misu T; Fujimori T; Sato S
    No To Shinkei; 2002 Jan; 54(1):5-21. PubMed ID: 11868352
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunological basis for the therapy of multiple sclerosis.
    Hohlfeld R
    Acta Neurol Belg; 1999 Mar; 99(1):40-3. PubMed ID: 10218091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunity to TCR peptides in multiple sclerosis. I. Successful immunization of patients with synthetic V beta 5.2 and V beta 6.1 CDR2 peptides.
    Bourdette DN; Whitham RH; Chou YK; Morrison WJ; Atherton J; Kenny C; Liefeld D; Hashim GA; Offner H; Vandenbark AA
    J Immunol; 1994 Mar; 152(5):2510-9. PubMed ID: 7510746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Recent progress in treatment for multiple sclerosis].
    Kira J
    Rinsho Shinkeigaku; 2000 Dec; 40(12):1261-3. PubMed ID: 11464473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Multiple sclerosis].
    Itoyama Y
    No To Shinkei; 2000 Dec; 52(12):1051-5. PubMed ID: 11193536
    [No Abstract]   [Full Text] [Related]  

  • 7. T cell vaccination in multiple sclerosis: hopes and facts.
    Zhang J; Raus J
    Acta Neurol Belg; 1994; 94(2):112-5. PubMed ID: 7518632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Therapeutic immunomodulation in neurology: from hope to reality. Exemplified by multiple sclerosis].
    Schluep M; Regli F
    Praxis (Bern 1994); 1995 Sep; 84(38):1021-4. PubMed ID: 7481299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic strategies in multiple sclerosis. I. Immunotherapy.
    Hohlfeld R
    Philos Trans R Soc Lond B Biol Sci; 1999 Oct; 354(1390):1697-710. PubMed ID: 10603621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Nervous system diseases with immunologic disorders--present status of immunotherapy].
    Ono R; Hamaguchi K
    Nihon Naika Gakkai Zasshi; 1993 Jan; 82(1):122-6. PubMed ID: 7681462
    [No Abstract]   [Full Text] [Related]  

  • 11. New treatments for multiple sclerosis.
    Poirier J
    Axone; 1999 Mar; 20(3):78-9. PubMed ID: 10401269
    [No Abstract]   [Full Text] [Related]  

  • 12. New treatments for multiple sclerosis.
    Hallpike JF
    Br J Hosp Med; 1980 Jan; 23(1):63-4, 66, 68. PubMed ID: 6153540
    [No Abstract]   [Full Text] [Related]  

  • 13. Antigen-specific therapies in multiple sclerosis: going beyond proteins and peptides.
    Fontoura P; Garren H; Steinman L
    Int Rev Immunol; 2005; 24(5-6):415-46. PubMed ID: 16318989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of multiple sclerosis: recent trials and future perspectives.
    Noseworthy JH; Gold R; Hartung HP
    Curr Opin Neurol; 1999 Jun; 12(3):279-93. PubMed ID: 10499173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of multiple sclerosis: current opinion].
    Yamamura T
    No To Shinkei; 2001 Aug; 53(8):707-13. PubMed ID: 11577411
    [No Abstract]   [Full Text] [Related]  

  • 16. Responses of purified T-cells to mitogens and myelin basic protein in multiple sclerosis.
    Sheremata W; Moscarello MA; Lopez D
    Trans Am Neurol Assoc; 1979; 104():103-6. PubMed ID: 95426
    [No Abstract]   [Full Text] [Related]  

  • 17. Degeneracy, as opposed to specificity, in immunotherapy.
    Hafler DA
    J Clin Invest; 2002 Mar; 109(5):581-4. PubMed ID: 11877465
    [No Abstract]   [Full Text] [Related]  

  • 18. T-cell recognition of an immunodominant myelin basic protein epitope in multiple sclerosis.
    Ota K; Matsui M; Milford EL; Mackin GA; Weiner HL; Hafler DA
    Nature; 1990 Jul; 346(6280):183-7. PubMed ID: 1694970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroimmunology of multiple sclerosis and experimental allergic encephalomyelitis.
    Stuerzebecher S; Martin R
    Neuroimaging Clin N Am; 2000 Nov; 10(4):649-68 ,vii-viii. PubMed ID: 11359717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cellular and humoral immune responses against autoreactive T cells in multiple sclerosis patients after T cell vaccination.
    Hermans G; Denzer U; Lohse A; Raus J; Stinissen P
    J Autoimmun; 1999 Sep; 13(2):233-46. PubMed ID: 10479392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.